Mental illness does not discriminate age, gender or race. Up to 50% of mental health patients fail their first treatment plan. Genomind Professional PGx Express is designed to change that...
Up to 50% of patients fail their first treatment plan. Genomind's breatkthrough mental health genetic test was designed to change that. Click here to learn more...
KING OF PRUSSIA, PA. November 9 2021 – Genomind®, a leading precision healthcare company, has named David Nash, MD, MBA the newest member of its Scientific Advisory Board (SAB).
Harmony United Psychiatric Care, a leading multi-city behavioral health practice and Genomind®, the leader in comprehensive digital mental health solutions, are teaming up to provide the newest tools for precision mental health services in Florida.
PHILADELPHIA, PA – May 03, 2021 – Audacy announced a multiplatform partnership with mental health innovator Genomind. This breakthrough partnership taps into Audacy’s influencers and Genomind’s personalized genetic insights to bring mental health conversations into the mainstream.
Genomind CEO Shawn O'Brien joined KAHI Sports Director and News Host, Casey Freelove, to discuss Genomind's tests and services, the impact of COVID-19 on the mental health space, as well as the company's recent partnership with NBA Athlete Kevin Love.
KING OF PRUSSIA, Pa., April 7, 2021
2200 Renaissance Blvd, Suite 100
877-895-8658
customerservice@genomind.com
